Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Guardian - UK
The Guardian - UK
Politics
Andrew Gregory and Natasha May

‘Extremely impressive’: melanoma jab trial results excite doctors

Nurse Christian Medina handles the needle used to administer a patient with his first jab at the University College London Hospital
After three years of follow up, the data suggests that levels of cancer relapse did not increase in people with high-risk, advanced stage melanoma. Photograph: Jordan Pettitt/PA

The world’s first personalised mRNA cancer vaccine for melanoma halves the risk of patients dying or the disease returning, according to trial results that doctors described as “extremely impressive”.

Melanoma affects more than 150,000 people a year globally, according to 2020 figures from World Cancer Research Fund International.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.